As you say the technology seems impressive and if it works it's possibly the next Cochlear, but lets face it, it's a long road and like any bio/med tech it's speculative until whatever it is they're developing is proven, approved, competitive, being used and making regular profits. Accordingly, that could take years, looks like there's confidence out there though to put that sort of moolah their way. If it takes off, great, if not, then such is life in the bio/med tech world.
- Forums
- ASX - By Stock
- EBR
- Ann: EBR Systems secures US$50m growth capital facility
Ann: EBR Systems secures US$50m growth capital facility, page-7
Featured News
Add EBR (ASX) to my watchlist
|
|||||
Last
$1.04 |
Change
-0.015(1.43%) |
Mkt cap ! $318.8M |
Open | High | Low | Value | Volume |
$1.04 | $1.04 | $1.01 | $20.71K | 19.98K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50 | $1.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.04 | 542 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50 | 1.030 |
1 | 50 | 1.025 |
2 | 11412 | 1.020 |
1 | 50 | 1.015 |
2 | 7256 | 1.010 |
Price($) | Vol. | No. |
---|---|---|
1.035 | 542 | 1 |
1.040 | 2500 | 1 |
1.045 | 1200 | 1 |
1.050 | 9383 | 1 |
1.070 | 9925 | 1 |
Last trade - 11.17am 19/06/2024 (20 minute delay) ? |
Featured News
EBR (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online